Page 18 of 32 · 749 questions tagged coa.
The particulars: method section · CPC. I am at the decision point and I would rather think it through than improvise. I would rather spend money on measurement than…
Numbers first: 96.4% · a C8 column · liraglutide. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone…
For reference: oral semaglutide · ten weeks · minus 80 °C. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with…
Numbers first: a sterility test · a five-person group buy. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can…
Setup, so nobody has to ask: orforglipron · two weeks · 4 °C. I am trying to build something sustainable rather than something thorough that I will abandon. I have…
Numbers first: 99.1% · a C8 column · oral semaglutide. This is presented as though it settles something, and I am not convinced it does. I have two documents that…
The lot number on the vial matches the certificate, which at least rules out the easy problem. I have done this once and I suspect I got away with it rather than got…
Conditions: 96.4% · a C4 column · dulaglutide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
What I have: 97.1% · a C8 column · liraglutide. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone…
This is my second independent submission on material from the same supplier. I would rather over-plan the first cycle and simplify later. I am prepared to do the work…
This is my second independent submission on material from the same supplier. This is presented as though it settles something, and I am not convinced it does. I have…
I have two third-party reports in front of me. Both say "identity confirmed by ESI-MS" and both include a spectrum, but the spectra look nothing like the single clean…
Numbers first: cagrilintide · six weeks · 4 °C. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum…
The case in front of me: CPC · oral semaglutide. I want to know whether there is evidence behind this or only repetition. I have checked the obvious registries and…
What I have: cagrilintide · lot-specific certificate. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone…
The pharmacy is accredited and I have verified that on the accreditor register. The empirical answer seems settled. The explanation does not. If the honest answer is…
Details up front: 98.8% · lot-specific certificate. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear…
I received a mapping report on tirzepatide. It states "sequence coverage: 100%" in bold at the top, and then the fragment table has exactly two entries in it.…
Conditions: list of related substances · SSA. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
What I am working with: BCH · a GLP-1 receptor agonist. This has the shape of a fact but I cannot find its origin. What I found instead were three secondary sources…
The specifics, since they change the answer: tirzepatide · three weeks · 30 °C. I am at the decision point and I would rather think it through than improvise. I would…
This is my second independent submission on material from the same supplier. This is a planning question. I know what my options are; I do not know how to weigh them.…
For reference: GL Biochem · semaglutide. Somebody stated this to me confidently and I would like to check it before repeating it. I would accept a well-reasoned…
Numbers first: 98.4% · a C8 column · tirzepatide. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone…